Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded as renamed to Atom Therapeutics Co., Ltd. (2025)
0
Ending by 2030
May 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 3, 2027The maintenance fee for Compound for treating or preventing hyperuricemia or gout (US 10,399,971) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,005,744 | Compounds for the Treatment or Prevention of Breast Cancer In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 10,399,971 | Compound for treating or preventing hyperuricemia or gout In force · From the USPTO record | In force | From the USPTO record | |
| US 11,597,725 | URAT1 Inhibitor for Promoting Uric Acid Excretion In force · High confidence | In force | High confidence | |
| US RE50,083 | URAT1 Inhibitor and Use Thereof In force · Low confidence | In force | Low confidence | |
| US 11,643,405 | Compound for Treatment or Prevention of Liver Diseases In force · High confidence | In force | High confidence | |
| US 12,780,806 | Xanthine Oxidase Inhibitor In force · High confidence | In force | High confidence |
Also on record, not counted in the 6: 1 patent in force now held by others · 1 lapsed for an unpaid fee · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending